Ribomic Balance Sheet Health
Financial Health criteria checks 6/6
Ribomic has a total shareholder equity of ¥3.4B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥3.5B and ¥155.8M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥3.40b |
Equity | JP¥3.39b |
Total liabilities | JP¥155.81m |
Total assets | JP¥3.55b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4591's short term assets (¥3.5B) exceed its short term liabilities (¥155.8M).
Long Term Liabilities: 4591 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 4591 is debt free.
Reducing Debt: 4591 has no debt compared to 5 years ago when its debt to equity ratio was 67.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4591 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4591 has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 12.1% each year.